Screening for recurrent breast cancer--its effectiveness and prognostic value

Area of Science:

• Oncology
• Breast Cancer Research
• Clinical Follow-up Studies

Background:

• Periodic follow-up examinations are standard post-mastectomy for breast cancer recurrence detection.
• The primary goal of screening is early intervention and improved patient survival.
• The efficacy of routine screening in conferring a survival benefit remains under investigation.

Purpose of the Study:

• To evaluate whether routine screening examinations after mastectomy significantly improve survival in breast cancer patients.
• To determine the proportion of recurrences detected asymptomatically versus symptomatically.
• To assess the impact of asymptomatic recurrence detection on patient survival.

Main Methods:

• Retrospective review of medical records for 1,230 women treated for invasive breast carcinoma.
• Identification and analysis of 248 cases of cancer recurrence.
• Comparison of survival rates between patients with asymptomatic versus symptomatic recurrences.

Main Results:

• Only 36% of breast cancer recurrences were detected asymptomatically.
• Asymptomatic recurrences were associated with favorable prognostic factors, including estrogen receptor (ER) positivity and node-negative status.
• Patients with asymptomatic recurrences exhibited superior survival compared to those with symptomatic recurrences, especially for occult local recurrences.

Conclusions:

• Routine screening after mastectomy identifies a limited number of asymptomatic recurrences.
• The improved survival observed with asymptomatic recurrence detection may be influenced by lead time and length bias rather than solely by screening efficacy.
• Current follow-up examination schedules do not appear to confer a significant survival advantage.